Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
about
An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data.The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cellsLocking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPVBrucine suppresses colon cancer cells growth via mediating KDR signalling pathway.Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.The effect of versican G3 domain on local breast cancer invasiveness and bony metastasisPhase II trial of paclitaxel-carboplatin with intercalated gefitinib for untreated, epidermal growth factor receptor gene mutation status unknown non-small cell lung cancer.Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN).Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy.Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.Addition of amino acid moieties to lapatinib increases the anti-cancer effect via amino acid transporters.The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.A c-Jun N-terminal kinase inhibitor, JNK-IN-8, sensitizes triple negative breast cancer cells to lapatinib.Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology.Dual-Color Fluorescence Imaging of EpCAM and EGFR in Breast Cancer Cells with a Bull's Eye-Type Plasmonic Chip.Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models.
P2860
Q33936078-B841895F-8401-4369-9BD9-DBA036685323Q34048154-C7FA467F-26EA-45FE-8DC3-6B8F7552E839Q34123748-974395DE-9505-4157-96A9-BCAF8063597BQ34154752-6C6BC53B-E25D-4952-9F2A-6AF4AF0C54CBQ34769614-741DC861-4A50-43BB-8AB4-44A9AE330847Q36393281-DE9C52E5-7A75-4402-9740-167840F57554Q36439401-EFB0C30F-5264-4000-A4DE-10848A3494FCQ36458742-54EECDA7-9CB0-4F9D-86AB-08E8CFC07B4CQ37310298-2802B32E-0F08-4F50-9F34-39C5620E31AAQ37624426-B8315AC6-C778-4CDD-B23D-B5DA538A0E81Q38914216-DD91930F-E366-4475-BD17-99075BD477C4Q39073102-A2484741-CFE9-44C8-9F49-CC3423995898Q39989937-5A2A9DD4-4533-42A7-877A-7CC9C5C8AADFQ45065769-4D915C7E-6E81-440D-8900-BD6FCB4C1AD5Q47113193-1F8E22C9-0C59-4B67-B90C-E0F90677B7B7Q47134459-AABBB94C-A05C-48A6-BDEE-187CC018F067Q47276713-AC64207E-761B-4955-A8ED-80DB7C41BC58Q51067834-4576280F-CB01-4CEC-B133-014983C5D0DB
P2860
Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor inhibitory effect of gef ...... lines (MCF7/ADR, MDA-MB-231).
@en
type
label
Tumor inhibitory effect of gef ...... lines (MCF7/ADR, MDA-MB-231).
@en
prefLabel
Tumor inhibitory effect of gef ...... lines (MCF7/ADR, MDA-MB-231).
@en
P2093
P356
P1476
Tumor inhibitory effect of gef ...... l lines (MCF7/ADR, MDA-MB-231)
@en
P2093
Daisuke Takabatake
Hirotoshi Takahashi
Hiroyoshi Doihara
Kensuke Kawasaki
Naruto Taira
Seiji Yoshitomi
Takeo Fujita
Yoichi Ishibe
Yutaka Ogasawara
P304
P356
10.1002/IJC.22187
P577
2007-01-01T00:00:00Z